» Authors » J G Hatlebakk

J G Hatlebakk

Explore the profile of J G Hatlebakk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 955
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dale H, Hatlebakk J, Hovdenak N, Ystad S, Lied G
Neurogastroenterol Motil . 2018 Mar; PMID: 29542844
Background: Non-coeliac gluten-sensitivity (NCGS) has been proposed as a new entity with unknown prevalence and mechanisms, and there is a need for a standardized procedure to confirm the diagnosis. The...
2.
Pham K, Havre R, Lango T, Hofstad E, Tangen G, Marvik R, et al.
Neurogastroenterol Motil . 2017 Nov; 30(4):e13252. PMID: 29144018
Background: In achalasia, muscle spasm may involve the proximal esophagus. When the muscle spasm is located in the proximal esophagus, conventional per oral endoscopic myotomy (POEM) may not be sufficient...
3.
Storlid E, Hausken T, Lied G, Gilja O, Hatlebakk J
Neurogastroenterol Motil . 2017 Nov; 30(4):e13249. PMID: 29119636
Background: Gastric accommodation to a meal may be important in the pathogenesis of upper gastrointestinal disorders, but has been difficult to investigate in a minimally invasive fashion. Methods: We studied...
4.
Mastracci L, Fiocca R, Engstrom C, Attwood S, Ell C, Galmiche J, et al.
Aliment Pharmacol Ther . 2017 Jun; 46(1):73-74. PMID: 28589583
No abstract available.
5.
Mastracci L, Fiocca R, Engstrom C, Attwood S, Ell C, Galmiche J, et al.
Aliment Pharmacol Ther . 2017 Mar; 45(10):1339-1349. PMID: 28326569
Background: Proton pump inhibitors and laparoscopic anti-reflux surgery (LARS) offer long-term symptom control to patients with gastro-oesophageal reflux disease (GERD). Aim: To evaluate the process of 'normalisation' of the squamous...
6.
Katle E, Hatlebakk J, Grimstad T, Kvaloy J, Steinsvag S
Rhinology . 2017 Feb; 55(1):27-33. PMID: 28214352
Introduction: The pathophysiology of chronic rhinosinusitis (CRS) is unclear. It has been discussed for decades whether gastro-oesophageal reflux (GOR) may be a contributing factor for some patients. The aim of...
7.
Hustoft T, Hausken T, Ystad S, Valeur J, Brokstad K, Hatlebakk J, et al.
Neurogastroenterol Motil . 2016 Oct; 29(4). PMID: 27747984
Background: A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) is increasingly recommended for patients with irritable bowel syndrome (IBS). We aimed to investigate the effects of a...
8.
Attwood S, Ell C, Galmiche J, Fiocca R, Hatlebakk J, Hasselgren B, et al.
Aliment Pharmacol Ther . 2015 Apr; 41(11):1162-74. PMID: 25858519
Background: Control of chronic gastro-oesophageal reflux disease may be achieved either by anti-reflux surgery (ARS) or by long-term medical therapy with proton pump inhibitors (PPIs). The primary efficacy results of...
9.
Hoff D, Krarup A, Lelic D, Olesen S, Dimcevski G, Hansen T, et al.
Neurogastroenterol Motil . 2013 Aug; 25(11):e718-27. PMID: 23965033
Background: Functional chest pain (FCP) of presumed esophageal origin is considered a common cause for chest pain in which central nervous system hyperexcitability is thought to play an important role....
10.
Jonasson C, Wernersson B, Hoff D, Hatlebakk J
Aliment Pharmacol Ther . 2013 Jan; 37(5):564-72. PMID: 23289763
Background: The diagnosis of gastro-oesophageal reflux disease (GERD) remains a challenge as both invasive methods and symptom-based strategies have limitations. The symptom-based management of GERD in primary care may be...